BioSpace News Archive

Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced the company received feedback from the European notified body on the Expanded Immunohematology (IH) submission.

Phanes Therapeutics, Inc. today announced that it has scheduled a company presentation at Biotech Showcase ™ 2022, to be held January 10–12, during the most important week in healthcare at the Hilton San Francisco Union Square.

Polydex Pharmaceuticals Limited (OTC Pink: POLXF) (the “Company”) reports financial results for the third quarter of fiscal 2022, the period ended October 31, 2021.

MDoloris Medical Systems, leader in the field of objective analgesia/nociception monitoring during anesthesia and in intensive care, and Mindray, a global leader in developing and providing advanced medical devices and solutions, announce today the CE Mark and upcoming launch of the Mdoloris ANI-MR module.

NEW YORK, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (or the “Company”) (NASDAQ: ATXI), a company focused on the development of intravenous (“IV”) tramadol for the U.S. market, today announced the closing of its public offering of 1,910,100 shares of common stock at a public offering price of $1.07. The gross proceeds of the offering were approximately $2.0 million before deducting underwriting discounts, commissions and offering expenses. In addition, the Company has granted

Abivax SA announces that Prof. Hartmut J. Ehrlich, M.D., CEO of Abivax, will present at the J.P. Morgan 40th Annual Healthcare Conference on Thursday, January 13, 2022 at 12:00-12:40 pm ET.

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that the U.S. Food and Drug Administration (“FDA”) has approved the Company’s abbreviated new drug application (“ANDA”) for vasopressin.

Predictive genetic testing are used to identify gene mutations pertaining to the disorders that surface at a considerably later stage in life after birth.

PCR systems offer qualitative detection of major pathogens including Cronobacter spp., Listeria, E. coli O157:H7, and Salmonella, and other important targets in environment and food.

Patient blood management (PBM) is a standard of care in the healthcare system, which offers to maximize the use of a patient’s own blood and avoid unnecessary blood transfusions during surgery.